← All trials
NCT06481995
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 9, 2024
- Primary completion
- Jun 30, 2028
- Completion date
- Dec 31, 2028
- First posted
- Jul 1, 2024
- Last posted
- Nov 8, 2024
- Enrollment
- 988
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ZurichLead sponsor
- Spital ZollikerbergOfficial
- University of ZurichSponsor investigator
- Cantonal Hospital of St. GallenOfficial
- Kantonsspital BadenOfficial
- University of GenevaOfficial
- University of BaselOfficial
- Cantonal Hospital WinterthurOfficial
- University of LausanneOfficial
- University of ZurichOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.